1,984
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Pomalidomide in multiple myeloma

, , , , , , , , & show all
Pages 133-137 | Received 17 Oct 2016, Accepted 16 Dec 2016, Published online: 26 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, Ernesto Vigna, Francesco Mendicino, Lucio Morabito, Katia Todoerti, Hamdi Al-Janazreh, Graziella D’Arrigo, Filippo Antonio Canale, Giovanna Cutrona, Antonino Neri, Massimo Martino & Massimo Gentile. (2021) Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Drug Design, Development and Therapy 15, pages 2969-2978.
Read now

Articles from other publishers (5)

Enrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Antonino Neri, Fortunato Morabito, Ernesto Vigna & Massimo Gentile. (2023) Teclistamab‐cqyv in multiple myeloma. European Journal of Haematology.
Crossref
Ali Tavakoli Pirzaman, Pouyan Ebrahimi, Amir Hossein Hasanpour, Mahdi Shakeri, Bahareh Babajani, Zahra Pourali Ganji, Hedye Babaei, Amirhossein Rahmati, Rezvan Hosseinzadeh, Shahrbanoo Doostmohamadian & Sohrab Kazemi. (2023) miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance. Technology in Cancer Research & Treatment 22.
Crossref
Natasha Mupeta Kaweme, Geoffrey Joseph Changwe & Fuling Zhou. (2021) Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects. Frontiers in Medicine 8.
Crossref
Massimo GENTILE, Fortunato MORABITO, Massimo MARTINO, Ernesto VIGNA, Enrica A. MARTINO, Francesco MENDICINO, Giovanni MARTINELLI & Claudio CERCHIONE. (2021) Chemotherapy-based regimens in multiple myeloma in 2020. Panminerva Medica 63:1.
Crossref
Khalid Ahmed Al-Anazi. 2019. Update on Multiple Myeloma. Update on Multiple Myeloma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.